๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial

โœ Scribed by Neil E Fleshner; M Scott Lucia; Blair Egerdie; Lorne Aaron; Gregg Eure; Indrani Nandy; Libby Black; Roger S Rittmaster

Book ID
117309387
Publisher
The Lancet
Year
2012
Tongue
English
Weight
217 KB
Volume
379
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Dutasteride in localised prostate cancer
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial
โœ Neil E Fleshner; M Scott Lucia; Blair Egerdie; Lorne Aaron; Gregg Eure; Indrani ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› The Lancet ๐ŸŒ English โš– 217 KB

Background We aimed to investigate the safety and effi cacy of dutasteride, a 5ฮฑ-reductase inhibitor, on prostate cancer progression in men with low-risk disease who chose to be followed up with active surveillance. Methods In our 3 year, randomised, double-blind, placebo-controlled study, undertak